Jason Scott Slakter, Chief Executive Officer at Ohr Pharmaceutical Inc (OHRP), bought 13,150 shares at $2.98 ($39K) on 2015-11-02, disclosed to the SEC on 2015-11-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.97 | 500 | $1K | 3.8% |
| 2 | $2.98 | 400 | $1K | 3.0% |
| 3 | $2.98 | 300 | $894 | 2.3% |
| 4 | $2.99 | 2,600 | $8K | 19.7% |
| 5 | $2.99 | 750 | $2K | 5.7% |
| 6 | $2.99 | 1,800 |
| $5K |
| 13.6% |
| 7 | $3.00 | 700 | $2K | 5.3% |
| 8 | $3.00 | 300 | $900 | 2.3% |
| 9 | $3.00 | 2,600 | $8K | 19.8% |
| 10 | $3.01 | 1,300 | $4K | 9.9% |
| 11 | $3.02 | 200 | $604 | 1.5% |
| 12 | $3.03 | 1,400 | $4K | 10.8% |
| 13 | $3.03 | 200 | $606 | 1.5% |
| 14 | $3.01 | 100 | $301 | 0.8% |
| Total | $3.00 avg | 13,150 | $39K | 100% |
| Filing → |
| OHRP | BUY | 2016-05-26 | $11K | — | Filing → |
| OHRP | BUY | 2016-05-25 | $89K | — | Filing → |
| OHRP | BUY | 2016-04-12 | $21K | — | Filing → |